Office of Research and Development, US Environmental Protection Agency, Las Vegas, NV, USA.
Expert Rev Clin Pharmacol. 2011 Mar;4(2):211-32. doi: 10.1586/ecp.11.6.
Active pharmaceutical ingredients (APIs) are ubiquitous environmental contaminants, resulting primarily from excretion and bathing and from disposal of leftover drugs by consumers and healthcare facilities. Although prudent disposal of leftover drugs has attracted the most attention for reducing API levels in the aquatic environment, a more effective approach would prevent the generation of leftover drugs in the first place. Many aspects of the practice of medicine and pharmacy can be targeted for reducing environmental contamination by APIs. These same modifications--focused on treating humans and the environment as a single, integral patient--could also have collateral outcomes with improved therapeutic outcomes, and with a reduced incidence of unintended poisonings, drug interactions and drug diversion, and lower consumer costs.
活性药物成分(APIs)是无处不在的环境污染物,主要来源于排泄、洗浴以及消费者和医疗机构处理剩余药物。虽然谨慎处理剩余药物已成为减少水环境中 API 水平的最受关注的方法,但更有效的方法是首先防止剩余药物的产生。医学和药学实践的许多方面都可以针对减少 API 对环境的污染进行改进。这些同样的改进措施——专注于将人类和环境视为一个单一的、完整的患者——也可能会带来更好的治疗效果、减少意外中毒、药物相互作用和药物滥用、以及降低消费者成本等意外收获。